Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Integra Lifesciences (NQ: IART )

31.30 -0.35 (-1.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Integra Lifesciences

< Previous 1 2 3 4 Next >
8 Analysts Have This To Say About Integra Lifesciences
Via Benzinga
For those who appreciate value investing, NASDAQ:IART is a compelling option with its solid fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART), an undervalued stock with good fundamentals. 
Via Chartmill
NASDAQ:IART appears to be flying under the radar despite its strong fundamentals.
Despite its impressive fundamentals, INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) remains undervalued. 
Via Chartmill
CrowdStrike, KKR, GoDaddy To Join S&P 500 In Quarterly Rebalance; Stocks Jump
KKR and GoDaddy also will join before the open on June 24. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Via Benzinga
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Via Benzinga
Recap: Integra Lifesciences Q4 Earnings
Via Benzinga
The Analyst Landscape: 7 Takes On Integra Lifesciences
Via Benzinga
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
NASDAQ:IART is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Investors should take notice ofINTEGRA LIFESCIENCES HOLDING (NASDAQ:IART)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during midday trading in New York on Monday, as traders continue to react positively... 
Via Benzinga
The Latest Analyst Ratings for Integra Lifesciences
Via Benzinga
4 Analysts Have This to Say About Integra Lifesciences
Via Benzinga
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
The Latest Analyst Ratings for Integra Lifesciences
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
9 Analysts Have This to Say About Integra Lifesciences
Via Benzinga
The Latest Analyst Ratings for Integra Lifesciences
Via Benzinga
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty Surgical and updates fiscal year 2024 guidance. 
Via Benzinga
IART Stock Earnings: Integra Lifesciences Meets EPS, Beats Revenue for Q1 2024
IART stock results show that Integra Lifesciences met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
NASDAQ:IART, an undervalued stock with good fundamentals.
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
Integra LifeSciences Holdings Corporation (NASDAQ: IART) agreed to acquire Acclarent Inc. 
Via Benzinga
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2023
Via Benzinga
7 Undervalued Stocks to Snag in This Red-Hot Market
Although the market may be soaring right now, you can still find compelling deals with the best undervalued stocks to buy. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.